T1	CHEM 169 193	talimogene laherparepvec
#1	AnnotatorNotes T1	C4754924; Talimogene laherparepvec only product; Pharmacologic Substance
T2	PROC 71 110	evaluar la supervivencia y la seguridad
T3	PROC 197 213	ensayos clínicos
#2	AnnotatorNotes T3	C0008976; Clinical Trials; Research Activity
T4	DISO 285 290	tumor
#3	AnnotatorNotes T4	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T5	PROC 360 374	ensayo clínico
#4	AnnotatorNotes T5	C0008976; Clinical Trials; Research Activity
T6	PROC 46 65	Estudio de registro
#5	AnnotatorNotes T6	C0920631; Patient Registry Study; Research Activity
T7	CHEM 329 353	talimogene laherparepvec
#6	AnnotatorNotes T7	C4754924; Talimogene laherparepvec only product; Pharmacologic Substance
T8	PROC 923 937	ensayo clínico
#7	AnnotatorNotes T8	C0008976; Clinical Trials; Research Activity
T9	DISO 990 995	tumor
#8	AnnotatorNotes T9	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T10	PROC 1024 1035	tratamiento
#9	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	PROC 464 488	consentimiento informado
#10	AnnotatorNotes T11	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T12	PROC 1068 1093	seguimiento a largo plazo
#11	AnnotatorNotes T12	C1517942; Long-term Follow-up; Health Care Activity
T13	PROC 1224 1238	ensayo clínico
#12	AnnotatorNotes T13	C0008976; Clinical Trials; Research Activity
T14	PROC 1323 1337	ensayo clínico
#13	AnnotatorNotes T14	C0008976; Clinical Trials; Research Activity
T15	CHEM 1193 1217	talimogene laherparepvec
#14	AnnotatorNotes T15	C4754924; Talimogene laherparepvec only product; Pharmacologic Substance
T16	PROC 1399 1424	seguimiento a largo plazo
#15	AnnotatorNotes T16	C1517942; Long-term Follow-up; Health Care Activity
T17	CHEM 1341 1365	talimogene laherparepvec
#16	AnnotatorNotes T17	C4754924; Talimogene laherparepvec only product; Pharmacologic Substance
T18	PROC 599 623	consentimiento informado
#17	AnnotatorNotes T18	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T19	PROC 682 706	consentimiento informado
#18	AnnotatorNotes T19	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T20	CHEM 892 916	talimogene laherparepvec
#19	AnnotatorNotes T20	C4754924; Talimogene laherparepvec only product; Pharmacologic Substance
T21	PROC 317 324	tratado
#20	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	Date 13 17	2015
T23	Date 111 124	a largo plazo
T24	LIVB 132 139	sujetos
#21	AnnotatorNotes T24	C0681850; Study Subject; Group
T25	LIVB 443 450	sujetos
#22	AnnotatorNotes T25	C0681850; Study Subject; Group
T26	LIVB 549 555	sujeto
#23	AnnotatorNotes T26	C0681850; Study Subject; Group
T27	Age 571 586	demasiado joven
T28	LIVB 628 647	representante legal
#24	AnnotatorNotes T28	C4288823; Legal Representative for the Study; Human
T29	LIVB 663 669	sujeto
#25	AnnotatorNotes T29	C0681850; Study Subject; Group
T30	LIVB 841 848	sujetos
#26	AnnotatorNotes T30	C0681850; Study Subject; Group
T31	Dose 870 888	al menos una dosis
T32	Date 1080 1093	a largo plazo
T34	LIVB 1152 1159	Sujetos
#27	AnnotatorNotes T34	C0681850; Study Subject; Group
T35	Date 1181 1192	actualmente
T36	LIVB 1272 1279	Sujetos
#28	AnnotatorNotes T36	C0681850; Study Subject; Group
T37	Date 1303 1314	actualmente
T38	Date 1411 1424	a largo plazo
A1	Status T10 History_of
A2	Status T12 History_of
A3	Status T20 History_of
A4	Status T8 History_of
#29	AnnotatorNotes T2	C0038953; Survival Analysis; Research Activity + C1705187; Safety Study; Research Activity
#30	AnnotatorNotes T38	C0443252; Long-term; Temporal Concept
#31	AnnotatorNotes T32	C0443252; Long-term; Temporal Concept
#32	AnnotatorNotes T23	C0443252; Long-term; Temporal Concept
#33	AnnotatorNotes T35	C0521116; Current (present time); Temporal Concept 
#34	AnnotatorNotes T37	C0521116; Current (present time); Temporal Concept 
R1	Overlap Arg1:T2 Arg2:T23	
R2	Experiences Arg1:T24 Arg2:T1	
T33	PROC 530 537	estudio
#35	AnnotatorNotes T33	C0008976; Clinical Trials; Research Activity
R3	Before Arg1:T11 Arg2:T33	
R4	Has_Age Arg1:T26 Arg2:T27	
R5	Overlap Arg1:T18 Arg2:T27	
R6	Has_Age Arg1:T29 Arg2:T27	
T39	Observation 707 719	asentimiento
#36	AnnotatorNotes T39	C1302239; Patient consented to clinical trial; Finding (?)
T40	PROC 819 826	estudio
#37	AnnotatorNotes T40	C0008976; Clinical Trials; Research Activity
R8	Before Arg1:T39 Arg2:T40	
R9	Before Arg1:T19 Arg2:T40	
R10	Before Arg1:T18 Arg2:T40	
A5	Status T7 History_of
A6	Status T1 History_of
R11	Used_for Arg1:T7 Arg2:T21	
R12	Experiences Arg1:T30 Arg2:T20	
R13	Has_Dose_or_Strength Arg1:T20 Arg2:T31	
R14	Overlap Arg1:T12 Arg2:T32	
T41	Quantifier_or_Qualifier 1010 1020	finalizado
#38	AnnotatorNotes T41	C1272693; Ended - status; Qualitative Concept
R15	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T41	
R16	Used_for Arg1:T20 Arg2:T10	
T42	Observation 1041 1054	participación
#39	AnnotatorNotes T42	C1278516; Patient participation status; Finding
R17	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T41	
R19	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T41	
R20	Experiences Arg1:T30 Arg2:T9	
R21	Experiences Arg1:T34 Arg2:T15	
R22	Overlap Arg1:T15 Arg2:T35	
R23	Experiences Arg1:T36 Arg2:T17	
R24	Overlap Arg1:T17 Arg2:T37	
R25	Overlap Arg1:T16 Arg2:T38	
R26	Overlap Arg1:T17 Arg2:T16	
A7	Experiencer T36 Patient
A8	Experiencer T34 Patient
A9	Experiencer T30 Patient
A10	Experiencer T25 Patient
A11	Experiencer T26 Patient
A12	Experiencer T28 Other
A13	Experiencer T29 Patient
A14	Experiencer T24 Patient
